In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Zepbound® (Tirzepatide, Injectable pen) by Eli Lilly has been FDA-approved since 2023 for Chronic weight management. Weight Method offers a separate option for Pacifica residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month — same pricing regardless of location.
FDA-approved Zepbound prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Pacifica is already seeing results
Zepbound in Pacifica, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Zepbound to patients in Pacifica from $329/month with virtual consultations and direct-to-door shipping.
For many people in Pacifica, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide addresses hormonal drivers involved in body weight regulation. Zepbound® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly, approved in 2023 for Chronic weight management. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The program is priced at $329/month, including the evaluation, the medication, ongoing care, and home delivery to Pacifica.
Suburban life around Pacifica comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Tirzepatide therapy addresses biology involved in weight regulation by reducing hunger signals, so Pacifica area residents can break patterns that willpower alone cannot fix. Weight Method prescribes compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy, at $329/month, delivered to your door. Compounded Tirzepatide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Zepbound from $329/month.
Get Started NowFree consultation. No commitment.